Resource: Integrative Approaches for Managing Chronic Infections
Naturopathic Strategies for Optimizing Prescription Based Therapy and Minimizing Collateral Damage in the Setting of Vector Borne Illness
While prescription antibiotic therapy is critical to treating vector borne illness (VBI), it is well established that antibiotic treatment for VBI may be associated with adverse effects. There is a growing body of evidence supporting the use of integrative therapies to minimize antibiotic and medication specific complications which can increase tolerability and thus efficacy of treatment protocols. Further, there is mounting evidence that specific naturopathic interventions may optimize antibiotic use/efficacy by addressing host characteristics that may perpetuate chronic infection.
The article below summarizes a literature review whose aim was to outline common prescription therapies and protocols utilized in VBI, identify their most common side effects and complications, and to recommend specific, evidence based, naturopathic adjunct care to minimize those side effects and complications.
Chronic infections do not result from a single pathogen or simple immune response. Instead, they often involve a web of interactions between multiple pathogens, the immune system, and host factors, contributing to immune dysregulation and inflammatory cycles. The "Lyme disease umbrella" exemplifies this complexity, capturing overlapping issues like immune dysfunction, autoimmune tendencies, mast cell activation, and co-infections. For example, tick-borne infections frequently involve co-infections that increase disease severity and complexity. Because traditional antibiotics often focus solely on eradicating pathogens, they may fail to address broader immune dysregulation and host health, necessitating a more comprehensive approach.
Antibiotics are essential in treating vector-borne infections, but they come with risks. Potential side effects include microbiome disruption, antibiotic resistance, Clostridium difficile infections, and organ toxicity. Integrative approaches can help to offset these side effects and support recovery:
Microbiome Support with Probiotics: Antibiotics can disrupt the gut microbiome, which can lead to conditions like antibiotic-associated diarrhea or dysbiosis. Probiotics, especially Saccharomyces boulardii and Lactobacillus strains, help to restore microbiome balance, reduce antibiotic-related diarrhea, and mitigate Clostridium difficile infections. Research supports that probiotics are effective adjuncts to antibiotics, helping to fill space in the microbiome to prevent pathogen overgrowth without colonizing the gut themselves.
Herbal Antimicrobials and Antifungals: Herbal agents, such as berberine, garlic, thyme, and black walnut, offer broad-spectrum antimicrobial properties that combat bacterial resistance, biofilm formation, and opportunistic infections, which are often exacerbated by prolonged antibiotic use. Berberine-containing herbs, for instance, are known for their anti-biofilm, anti-resistance, and broad-spectrum antimicrobial properties, making them especially useful in cases of multidrug-resistant pathogens. These herbs work not only by killing pathogens but also by modifying bacterial mechanisms, preventing resistance development, and supporting the immune system.
Anti-inflammatory and Herxheimer Reaction Support: The Herxheimer reaction, a temporary worsening of symptoms due to bacterial die-off, is common during the early stages of antibiotic treatment for spirochetal infections. Naturopathic interventions, such as vitamin C, quercetin, glutathione, and cytokine-modulating herbs like Scutellaria baicalensis, help manage the inflammation and oxidative stress caused by these reactions. These compounds support the body’s detoxification pathways and modulate immune responses to keep inflammation manageable and reduce patient discomfort.
Detoxification and Organ Support: Herbal and supplemental strategies can also protect organs and promote detoxification during antibiotic therapy. For instance, milk thistle and glutathione support liver function, protecting against the hepatotoxic effects of drugs like amoxicillin-clavulanate, while activated charcoal and zeolite are useful for binding toxins released by dying bacteria. Regular blood work, hydration, and supportive treatments can monitor and maintain organ health, especially for patients on prolonged antibiotic regimens.
Certain botanical compounds have been shown to work synergistically with antibiotics, increasing their efficacy against both antibiotic-sensitive and resistant pathogens. For example:
Scutellaria baicalensis: This herb has demonstrated a synergistic effect with doxycycline, enhancing its activity against Borrelia and Babesia species, common coinfections in Lyme disease. Its bioactives, such as baicalein, enhance the immune response, reduce bacterial adherence, and help overcome antibiotic resistance.
Cryptolepis sanguinolenta, Polygonum cuspidatum, and Uncaria tomentosa: These herbs target persistent bacterial forms and biofilms, supporting antibiotic action against “persister cells”—bacteria that have entered a dormant state and are often resistant to conventional antibiotics.
These botanicals are capable of enhancing antibiotic absorption, modulating drug biotransformation, reducing pathogen adhesion to host cells, and inhibiting bacterial mechanisms like efflux pumps and quorum sensing that pathogens use to evade treatment. This synergistic approach reduces the likelihood of resistance development and expands treatment efficacy by addressing both the pathogen and its survival mechanisms.
Mitochondrial dysfunction is a common feature in chronic infections, exacerbated by both the infection and antibiotic treatment. Integrative therapies aim to support mitochondrial health, helping patients maintain energy levels and immune function. Coenzyme Q10, carnitine, and alpha-lipoic acid are beneficial for supporting cellular energy production, reducing oxidative stress, and aiding recovery from infection-related fatigue.
Oxidative therapies, such as high-dose vitamin C and ozone therapy, have been shown to transiently increase reactive oxygen species (ROS), which can stimulate immune function and have direct antimicrobial effects. These therapies are used temporarily to boost the body's natural defenses, providing additional support for immune-compromised patients.
No single treatment approach will suit every patient, given the variability in host responses, immune status, and individual health profiles. Practitioners assess factors such as symptom severity, co-infections, immune status, and specific areas of dysfunction (e.g., nervous system or gut health) to customize treatment. The goal is to create an integrative protocol that addresses five key areas: pathogen elimination, antibiotic synergy, immune modulation, support for weakened systems, and symptom management.
In conclusion, our literature review brought about several discussion points:
Evidence for Naturopathic Adjunct Care: There is a growing body of evidence that naturopathic adjunct care can be beneficial alongside antibiotic protocols for vector-borne infections (VBIs). This integrative approach not only mitigates common side effects but also addresses patient-specific factors that perpetuate chronic infections.
Enhanced Tolerability and Compliance: Addressing common side effects and complications can improve patient compliance with prescription-based protocols. Increased tolerability of antibiotics ultimately boosts the efficacy of these protocols, as patients are better able to adhere to their treatment plan.
Impact on Host-Infection Interaction: Naturopathic interventions can increase the efficacy of antibiotics by addressing the host-pathogen interaction, going beyond the “kill the bug” mindset. This holistic approach manages underlying dysfunctions in the host that contribute to chronic infection, supporting sustainable recovery.
Need for Further Research: While many naturopathic interventions have shown promise in clinical and anecdotal contexts, high-quality evidence is lacking for some commonly used treatments. This gap highlights an essential need for more research to support and refine integrative approaches in managing chronic infections.
Our Lyme Literacy Course for Healthcare Practitioners course includes 10+ modules with additional resources that will leave you feeling confident and well-equipped to treat Lyme and Chronic Complex Disease.
Sign up for a free module
References
References - herbal therapy antibiotic resistance
Gupta PD, Birdi TJ. Development of botanicals to combat antibiotic resistance. Journal of Ayurveda and Integrative Medicine. 2017;8(4):266-275. doi:10.1016/j.jaim.2017.05.004
Anand U, Jacobo-Herrera N, Altemimi A, Lakhssassi N. A comprehensive review on medicinal plants as antimicrobial therapeutics: Potential avenues of Biocompatible Drug Discovery. Metabolites. 2019;9(11):258. doi:10.3390/metabo9110258
Álvarez-Martínez FJ, Barrajón-Catalán E, Micol V. Tackling antibiotic resistance with compounds of natural origin: A comprehensive review. Biomedicines. 2020;8(10):405. doi:10.3390/biomedicines8100405
Vaou N, Stavropoulou E, Voidarou C, Tsigalou C, Bezirtzoglou E. Towards advances in medicinal plant antimicrobial activity: A review study on challenges and future perspectives. Microorganisms. 2021;9(10):2041. doi:10.3390/microorganisms9102041
Kuete V, Alibert-Franco S, Eyong KO, et al. Antibacterial activity of some natural products against bacteria expressing a multidrug-resistant phenotype. Int J Antimicrob Agents. 2011;37(2):156-161. doi:10.1016/j.ijantimicag.2010.10.020
Mishra R, Panda AK, De Mandal S, Shakeel M, Bisht SS, Khan J. Natural Anti-biofilm Agents: Strategies to Control Biofilm-Forming Pathogens. Front Microbiol. 2020;11:566325. Published 2020 Oct 29. doi:10.3389/fmicb.2020.566325
Stavri M, Piddock LJ, Gibbons S. Bacterial efflux pump inhibitors from natural sources. J Antimicrob Chemother. 2007;59(6):1247-1260. doi:10.1093/jac/dkl460
Shamim A, Ali A, Iqbal Z, et al. Natural Medicine a Promising Candidate in Combating Microbial Biofilm. Antibiotics (Basel). 2023;12(2):299. Published 2023 Feb 2. doi:10.3390/antibiotics12020299
Harakeh S, Khan I, Almasaudi SB, Azhar EI, Al-Jaouni S, Niedzweicki A. Role of Nutrients and Phyto-compounds in the Modulation of Antimicrobial Resistance. Curr Drug Metab. 2017;18(9):858-867. doi:10.2174/1389200218666170719095344
References- probiotics
McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol. 2006;101(4):812-822. doi:10.1111/j.1572-0241.2006.00465.x
Tung JM, Dolovich LR, Lee CH. Prevention of Clostridium difficile infection with Saccharomyces boulardii: a systematic review. Can J Gastroenterol. 2009;23(12):817-821. doi:10.1155/2009/915847
Hempel S, Newberry SJ, Maher AR, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA. 2012;307(18):1959-1969. doi:10.1001/jama.2012.3507 (2012!!)
Goldenberg JZ, Yap C, Lytvyn L, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2017;12(12):CD006095. Published 2017 Dec 19. doi:10.1002/14651858.CD006095.pub4
Goodman C, Keating G, Georgousopoulou E, Hespe C, Levett K. Probiotics for the prevention of antibiotic-associated diarrhoea: a systematic review and meta-analysis. BMJ Open. 2021;11(8):e043054. Published 2021 Aug 12. doi:10.1136/bmjopen-2020-043054
(saccharomyces boulardii) AND (clostridium difficile)
Szajewska H, Kołodziej M. Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 2015;42(7):793-801. doi:10.1111/apt.13344
Madoff SE, Urquiaga M, Alonso CD, Kelly CP. Prevention of recurrent Clostridioides difficile infection: A systematic review of randomized controlled trials. Anaerobe. 2020;61:102098. doi:10.1016/j.anaerobe.2019.102098
References - broad spectrum antimicrobial + antiresistance
Mishra R, Panda AK, De Mandal S, Shakeel M, Bisht SS, Khan J. Natural Anti-biofilm Agents: Strategies to Control Biofilm-Forming Pathogens. Front Microbiol. 2020;11:566325. Published 2020 Oct 29. doi:10.3389/fmicb.2020.566325
Tong Y, Zhang J, Sun N, et al. Berberine reverses multidrug resistance in Candida albicans by hijacking the drug efflux pump Mdr1p. Sci Bull (Beijing). 2021;66(18):1895-1905. doi:10.1016/j.scib.2020.12.035
Wojtyczka RD, Dziedzic A, Kępa M, et al. Berberine enhances the antibacterial activity of selected antibiotics against coagulase-negative Staphylococcus strains in vitro. Molecules. 2014;19(5):6583-6596. Published 2014 May 22. doi:10.3390/molecules19056583
Li X, Song Y, Wang L, et al. A Potential Combination Therapy of Berberine Hydrochloride With Antibiotics Against Multidrug-Resistant Acinetobacter baumannii. Front Cell Infect Microbiol. 2021;11:660431. Published 2021 Mar 25. doi:10.3389/fcimb.2021.660431
da Silva AR, de Andrade Neto JB, da Silva CR, et al. Berberine Antifungal Activity in Fluconazole-Resistant Pathogenic Yeasts: Action Mechanism Evaluated by Flow Cytometry and Biofilm Growth Inhibition in Candida spp. Antimicrob Agents Chemother. 2016;60(6):3551-3557. Published 2016 May 23. doi:10.1128/AAC.01846-15
Jafri H, Ahmad I. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis. J Mycol Med. 2020;30(1):100911. doi:10.1016/j.mycmed.2019.100911
Benameur Q, Gervasi T, Pellizzeri V, et al. Antibacterial activity of Thymus vulgaris essential oil alone and in combination with cefotaxime against blaESBL producing multidrug resistant Enterobacteriaceae isolates. Nat Prod Res. 2019;33(18):2647-2654. doi:10.1080/14786419.2018.1466124
Fani MM, Kohanteb J, Dayaghi M. Inhibitory activity of garlic (Allium sativum) extract on multidrug-resistant Streptococcus mutans. J Indian Soc Pedod Prev Dent. 2007;25(4):164-168. doi:10.4103/0970-4388.37011
Magryś A, Olender A, Tchórzewska D. Antibacterial properties of Allium sativum L. against the most emerging multidrug-resistant bacteria and its synergy with antibiotics. Arch Microbiol. 2021;203(5):2257-2268. doi:10.1007/s00203-021-02248-z
Bhatwalkar SB, Mondal R, Krishna SBN, Adam JK, Govender P, Anupam R. Antibacterial Properties of Organosulfur Compounds of Garlic (Allium sativum). Front Microbiol. 2021;12:613077. Published 2021 Jul 27. doi:10.3389/fmicb.2021.613077
Lu M, Dai T, Murray CK, Wu MX. Bactericidal Property of Oregano Oil Against Multidrug-Resistant Clinical Isolates [published correction appears in Front Microbiol. 2021 Jul 12;12:713573]. Front Microbiol. 2018;9:2329. Published 2018 Oct 5. doi:10.3389/fmicb.2018.02329
Barbosa LN, Alves FCB, Andrade BFMT, et al. Proteomic analysis and antibacterial resistance mechanisms of Salmonella Enteritidis submitted to the inhibitory effect of Origanum vulgare essential oil, thymol and carvacrol. J Proteomics. 2020;214:103625. doi:10.1016/j.jprot.2019.103625
Ho KV, Schreiber KL, Vu DC, et al. Black Walnut (Juglans nigra) Extracts Inhibit Proinflammatory Cytokine Production From Lipopolysaccharide-Stimulated Human Promonocytic Cell Line U-937. Front Pharmacol. 2019;10:1059. Published 2019 Sep 19. doi:10.3389/fphar.2019.01059
Ho KV, Lei Z, Sumner LW, et al. Identifying Antibacterial Compounds in Black Walnuts (Juglans nigra) Using a Metabolomics Approach. Metabolites. 2018;8(4):58. Published 2018 Sep 29. doi:10.3390/metabo8040058
Zhang J, Hunto ST, Yang Y, Lee J, Cho JY. Tabebuia impetiginosa: A Comprehensive Review on Traditional Uses, Phytochemistry, and Immunopharmacological Properties. Molecules. 2020;25(18):4294. Published 2020 Sep 18. doi:10.3390/molecules25184294
Khan S, Imran M, Imran M, Pindari N. Antimicrobial activity of various ethanolic plant extracts against pathogenic multi drug resistant Candida spp. Bioinformation. 2017;13(3):67-72. Published 2017 Mar 31. doi:10.6026/97320630013067
Hsu H, Sheth CC, Veses V. Herbal Extracts with Antifungal Activity against Candida albicans: A Systematic Review. Mini Rev Med Chem. 2021;21(1):90-117. doi:10.2174/1389557520666200628032116